Results 191 to 200 of about 1,972,994 (257)
Turnbull procedure-analysis of a cohort in the salvage setting. [PDF]
Arlt G, Doyon F, Magdeburg R, Kienle P.
europepmc +1 more source
Knowledge, Attitudes, and Practices Toward LARS Prevention in Rectal Cancer Patients With Prophylactic Stomas: A Multicenter Cross-Sectional Study. [PDF]
Liu N, Pi HY, Sun YZ, Wang TZ.
europepmc +1 more source
Transanal irrigation for low anterior resection syndrome treatment: international multicentre randomized clinical trial. [PDF]
Civilka I +6 more
europepmc +1 more source
Structured pelvic floor physiotherapy rehabilitation for low anterior resection syndrome in colorectal cancer: An Australian feasibility study. [PDF]
Chan KYC +5 more
europepmc +1 more source
ABSTRACT In a recent publication, Lapitz et al. reported differences in serum levels that predict the development of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis prior to clinical manifestation. We examined whether these biomarkers also predict the risk of gallbladder cancer (GBC) in European prospective plasma samples from ...
Linda Zollner +4 more
wiley +1 more source
Bowel Stimulation Before Loop Ileostomy Closure Using Probiotics: Study Protocol for a Randomized Controlled Trial at a Single Center. [PDF]
Kim KE, Bae SU, Baek SK, Jeong WK.
europepmc +1 more source
ABSTRACT Evidence to guide the treatment for patients with metastatic castration‐resistant prostate cancer (mCRPC) and Homologous Recombination Repair (HRR) gene alterations outside of clinical trials remains limited. This was an observational, cohort study, including mCRPC patients with tumor harboring HRR alterations, progressed on a prior androgen ...
Lorena Incorvaia +35 more
wiley +1 more source
Distinct trajectories of low anterior resection syndrome following ileostomy reversal. [PDF]
Zhang X +7 more
europepmc +1 more source
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor +8 more
wiley +1 more source

